Evidence Synthesis
Bayer Crop Science reported a strong quarterly earnings beat with its 33.98 INR, exceeding analyst expectations.
Loading stock analysis…
Loading stock analysis…
Evidence Synthesis
Last synthesized: 6 Sept 2026, 00:25
See how this stock's evidence score moved across recent sessions — unlock Pro for the live chart.
Full momentum history unlocks with Pro or Research.
Evidence Synthesis
Bayer Crop Science reported a strong quarterly earnings beat with its 33.98 INR, exceeding analyst expectations.
Source observations behind the synthesis narrative.
| Metric | Value | Trend | |
|---|---|---|---|
| GROSS_MARGIN | 41.76 % | 17.3 | ▲ |
| MARGINAL_OPERATING_LEVERAGE | 17.3 % | 13.08 | ▲ |
| REVENUE_GROWTH_YOY | -4.2 % | 15.4 | ▼ |
| EPS_ACTUAL | 33.98 INR | 21.29 | ▲ |
| EPS_SURPRISE_PERCENT | -0.143 % | 0.121 | ▼ |
| PRICE_CHANGE_PERCENT | 0.863 % | — | - |
| DAILY_VOLUME | 9,989 shares | 35,519 | ▼ |
| CLOSE_PRICE | 3,995 INR | 3,960.8 | ▲ |
| NEWS_SENTIMENT_SCORE | 0.63 score | — | - |
| ANALYST_STRONG_BUY_COUNT | 2 count | 3 | ▼ |
| TARGET_PRICE_PREMIUM | 28.32 % | — | - |